Should advanced perfusion be the standard of care for donation after circulatory death liver transplant?

Abstract

As an alternative to static cold storage (SCS), advanced perfusion techniques such as normothermic regional perfusion (NRP) and ex-situ perfusion (normothermic or hypothermic) have emerged as a way to improve the ischemic injury suffered by DCD livers. Multiple studies have been published that have demonstrated superior post-DCD liver transplant outcomes when using advanced perfusion compared to SCS. In particular, these studies have shown lower rates of ischemic cholangiopathy with advanced perfusion. In addition to the improved post-liver transplant outcomes, studies have also demonstrated higher rates liver utilization from DCD donors when advanced perfusion is used compared to SCS. Given the high rates of graft loss in patients who develop ischemic cholangiopathy, the significant reduction seen in DCD donor livers that have undergone advanced perfusion, represents a key step in more broad utilization of these livers. With such compelling evidence from multiple trials, it seems reasonable to ask the question: should advanced perfusion be the standard of care for DCD liver transplant?